Revision of USP Chapter on IR Spectroscopy
Recommendation
10/11 September 2025
Register now for ECA's GMP Newsletter
In the Pharmacopeial Forum No 39(2), the USP has published the draft for the revised General Chapter <854> on Mid-Infrared Spectroscopy. This draft is the second one and takes into consideration the comments sent to the USP.
Some acceptance criteria for some of the single validation parameters have been adapted in the validation of IR methods. Regarding accuracy, the recovery rate has been added to 95.0% - 105.0% for drug product assay.
Regarding precision, the relative standard deviation for repeatability is set as follows:
- Not more than 1.0% for APIs
- Not more than 2.0% for medicinal products
- Not more than 20.0% for impurities
And for intermediate precision:
- Not more than 1.0% for APIs
- Not more than 3.0% for medicinal products
- Not more than 25.0% for impurities
In addition to revised Chapter <854>, there will also be the new General USP Chapter <1854> which describes theory and practice of Mid Infrared Spectroscopy.
Both documents can be found on the Pharmacopeial Forum of the USP website.
Related GMP News
14.07.2025Inadequate Sampling and Component Testing Highlighted in FDA Warning Letter
14.07.2025EMA publishes new Product-Specific Bioequivalence Guidance
14.07.2025Revision of USP Chapter <1039> Chemometrics Published for Comments
14.07.2025Proposal for new USP Chapter <318> NMR Monomer Ratio Determination for Lactide-Glycolide Polymers
14.07.2025New USP Chapter <1221> on Ongoing Procedure Performance Verification (OPPV) Published for Comment
02.07.2025FDA Warning Letter: Missing Testing, No Stability Data, and Inadequate Raw Material Controls